These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 8172608)

  • 1. Subcellular localization and translocation of the receptor for N-formylmethionyl-leucyl-phenylalanine in human neutrophils.
    Sengeløv H; Boulay F; Kjeldsen L; Borregaard N
    Biochem J; 1994 Apr; 299 ( Pt 2)(Pt 2):473-9. PubMed ID: 8172608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subcellular localization and dynamics of Mac-1 (alpha m beta 2) in human neutrophils.
    Sengeløv H; Kjeldsen L; Diamond MS; Springer TA; Borregaard N
    J Clin Invest; 1993 Sep; 92(3):1467-76. PubMed ID: 8376598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human neutrophil Fc gamma RIIIB and formyl peptide receptors are functionally linked during formyl-methionyl-leucyl-phenylalanine-induced chemotaxis.
    Kew RR; Grimaldi CM; Furie MB; Fleit HB
    J Immunol; 1992 Aug; 149(3):989-97. PubMed ID: 1321856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil control of formylmethionyl-leucyl-phenylalanine induced mobilization of secretory vesicles and NADPH-oxidase activation: effect of an association of the ligand-receptor complex to the cytoskeleton.
    Lundqvist H; Gustafsson M; Johansson A; Särndahl E; Dahlgren C
    Biochim Biophys Acta; 1994 Oct; 1224(1):43-50. PubMed ID: 7948041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a human neutrophil protein of Mr 24 000 that binds N-formyl peptides: co-sedimentation with specific granules.
    Allen RA; Erickson RW; Jesaitis AJ
    Biochim Biophys Acta; 1989 Apr; 991(1):123-33. PubMed ID: 2653446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcellular distribution and characterization of GTP-binding proteins in human neutrophils.
    Khachatrian L; Rubins JB; Manning EC; Dexter D; Tauber AI; Dickey BF
    Biochim Biophys Acta; 1990 Sep; 1054(2):237-45. PubMed ID: 2169312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucosal subepithelial binding sites for the bacterial chemotactic peptide, formyl-methionyl-leucyl-phenylalanine (FMLP).
    Anton P; O'Connell J; O'Connell D; Whitaker L; O'Sullivan GC; Collins JK; Shanahan F
    Gut; 1998 Mar; 42(3):374-9. PubMed ID: 9577344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rebamipide suppresses formyl-methionyl-leucyl-phenylalanine (fMLP)-induced superoxide production by inhibiting fMLP-receptor binding in human neutrophils.
    Nagano C; Azuma A; Ishiyama H; Sekiguchi K; Imagawa K; Kikuchi M
    J Pharmacol Exp Ther; 2001 Apr; 297(1):388-94. PubMed ID: 11259567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secretory vesicles are the intracellular reservoir of complement receptor 1 in human neutrophils.
    Sengeløv H; Kjeldsen L; Kroeze W; Berger M; Borregaard N
    J Immunol; 1994 Jul; 153(2):804-10. PubMed ID: 8021514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effects of spinorphin, a novel endogenous regulator, on chemotaxis, O2- generation, and exocytosis by N-formylmethionyl-leucyl-phenylalanine (FMLP)-stimulated neutrophils.
    Yamamoto Y; Kanazawa T; Shimamura M; Ueki M; Hazato T
    Biochem Pharmacol; 1997 Sep; 54(6):695-701. PubMed ID: 9310346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cigarette smoking increases neutrophil formyl methionyl leucyl phenylalanine receptor numbers.
    Matheson M; Rynell AC; McClean M; Berend N
    Chest; 2003 May; 123(5):1642-6. PubMed ID: 12740285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lateral segregation of neutrophil chemotactic receptors into actin- and fodrin-rich plasma membrane microdomains depleted in guanyl nucleotide regulatory proteins.
    Jesaitis AJ; Bokoch GM; Tolley JO; Allen RA
    J Cell Biol; 1988 Sep; 107(3):921-8. PubMed ID: 3138250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A derivative of wheat germ agglutinin specifically inhibits formyl-peptide-induced polymorphonuclear leukocyte chemotaxis by blocking re-expression (or recycling) of receptors.
    Perez HD; Elfman F; Lobo E; Sklar L; Chenoweth D; Hooper C
    J Immunol; 1986 Mar; 136(5):1803-12. PubMed ID: 3753993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of N-formyl-methionyl-leucyl-phenylalanine (fMLP) binding to isolated human neutrophils.
    Psychoyos S; Smith CW
    Agents Actions; 1989 Mar; 26(3-4):372-7. PubMed ID: 2735228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunochemical characterization of the formyl peptide receptor moieties on human neutrophils.
    De Nardin E; Genco RJ
    Hybridoma; 1991 Feb; 10(1):49-63. PubMed ID: 1709613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does formyl-methionyl-leucyl-phenylalanine exert a physiological role in labor in women?
    Buzzi M; Vesce F; Ferretti ME; Fabbri E; Biondi C
    Biol Reprod; 1999 May; 60(5):1211-6. PubMed ID: 10208986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcellular distribution and mobilization of MAC-1 (CD11b/CD18) in neonatal neutrophils.
    Jones DH; Schmalstieg FC; Dempsey K; Krater SS; Nannen DD; Smith CW; Anderson DC
    Blood; 1990 Jan; 75(2):488-98. PubMed ID: 2153038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal adaptation of neutrophil oxidative responsiveness to n-formyl-methionyl-leucyl-phenylalanine. Acceleration by granulocyte-macrophage colony stimulating factor.
    English D; Broxmeyer HE; Gabig TG; Akard LP; Williams DE; Hoffman R
    J Immunol; 1988 Oct; 141(7):2400-6. PubMed ID: 3049807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased fMet-Leu-Phe receptor expression and altered superoxide production of neutrophil granulocytes in septic and posttraumatic patients.
    Tschaikowsky K; Sittl R; Braun GG; Hering W; Rügheimer E
    Clin Investig; 1993 Dec; 72(1):18-25. PubMed ID: 8136611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporin H is a potent and selective formyl peptide receptor antagonist. Comparison with N-t-butoxycarbonyl-L-phenylalanyl-L-leucyl-L-phenylalanyl-L- leucyl-L-phenylalanine and cyclosporins A, B, C, D, and E.
    Wenzel-Seifert K; Seifert R
    J Immunol; 1993 May; 150(10):4591-9. PubMed ID: 8387097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.